Event Brief
Mar 10, 2026 at 10:04 AM ET
FDA Approves Leucovorin for Rare Genetic Disorder
By The BriefBrief
Leucovorin is now the first approved treatment for a rare genetic disorder, following its controversial promotion for autism.
WHO: Food and Drug Administration
WHAT: Approved leucovorin as a treatment for a rare genetic disorder
WHEN: Mar 10, 2026 at 9:17 AM ET
WHERE: USA
WHY: To provide a treatment for cerebral folate deficiency
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21419 of 21419
Same format. Every time.
Continue reading — sign in or create a free account with
